However, BPC 157 is a therapeutic agent not approved by the FDA, which cites risk of immunogenicity, peptide-related impurities, and limited safety-related information as reasons for banning BPC-157
Should BPC-157 be used without medical supervision
clinical oversight is warranted
In rare cases, they can cause more serious side effects such as: Pancreatitis (inflammation of the pancreas) Hypoglycemia (low blood sugar) Kidney problems Gallbladder problems Allergic reactions Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, persistent nausea or vomiting, rapid heartbeat, difficulty breathing, or swelling of the face, lips, tongue, or throat
Shows distinct binding dynamics versus native amylin and salmon calcitonin, with cryoEM data indicating unique conformational effects on CTR/RAMP complexes that may underlie its robust and durable anorectic activity
M.MarsW